Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MORA Cure for Knee Osteoarthritis With Anterior Knee Pain

NCT: NCT07769593 · ACTIVE_NOT_RECRUITING

NCT IDNCT07769593
StatusACTIVE_NOT_RECRUITING
Start Date2026-07-10
Completion2027-02-28
SponsorEverEx Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This prospective, multicenter, single-arm, sponsor-initiated pilot study will evaluate the clinical course and safety of MORA Cure in adults older than 50 years with knee osteoarthritis accompanied by anterior knee pain. Participants will use MORA Cure for 8 weeks. MORA Cure provides personalized rehabilitation exercises and cognitive behavioral therapy-based content through a patient mobile application supported by a clinician web portal. Clinical outcomes will be assessed at baseline, Week 4, and Week 8. The planned enrollment is 44 participants at two sites in the Republic of Korea.

Frequently Asked Questions

What is MORA Cure for Knee Osteoarthritis With Anterior Knee Pain?

MORA Cure for Knee Osteoarthritis With Anterior Knee Pain is a clinical trial registered under NCT07769593. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07769593?

The current status of NCT07769593 (MORA Cure for Knee Osteoarthritis With Anterior Knee Pain) is: ACTIVE_NOT_RECRUITING.

When did MORA Cure for Knee Osteoarthritis With Anterior Knee Pain start?

MORA Cure for Knee Osteoarthritis With Anterior Knee Pain started on 2026-07-10.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.